Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,168 | -6,815 | -17,123 | -10,781 | -7,139 |
| Depreciation Amortization | 130 | 79 | 185 | 135 | 85 |
| Accounts payable and accrued liabilities | 1,627 | -63 | 521 | 384 | 179 |
| Other Working Capital | 229 | 383 | 1,950 | 486 | 236 |
| Other Operating Activity | -644 | 359 | -167 | -220 | -85 |
| Operating Cash Flow | $-15,826 | $-6,057 | $-14,634 | $-9,996 | $-6,724 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -138 | -62 | -203 | -203 | -197 |
| Purchase Of Investment | -224,602 | -64,711 | -24,178 | N/A | N/A |
| Investing Cash Flow | $-224,740 | $-64,773 | $-24,381 | $-203 | $-197 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30 | 23 | 202 | 202 | 135 |
| Other Financing Activity | 186,024 | 186,927 | 120,076 | 25,075 | 0 |
| Financing Cash Flow | $186,054 | $186,950 | $120,278 | $25,277 | $135 |
| Beginning Cash Position | 104,916 | 104,916 | 23,653 | 23,653 | 23,653 |
| End Cash Position | 50,404 | 221,036 | 104,916 | 38,731 | 16,867 |
| Net Cash Flow | $-54,512 | $116,120 | $81,263 | $15,078 | $-6,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,826 | -6,057 | -14,634 | -9,996 | -6,724 |
| Capital Expenditure | -138 | -62 | -203 | -203 | -197 |
| Free Cash Flow | -15,964 | -6,119 | -14,837 | -10,199 | -6,921 |